A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure
Clinical trial NCT07562087 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07562087
- Sponsor
- Tarsus Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-09
- Primary completion
- 2027-10-01
- Enrollment
- 722
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.